For: |
Ching SS, Sabanathan S, Jenkinson LR. Treatment of |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v14/i24/3855.htm |
Number | Citing Articles |
1 |
Dariush Mirsattari, Homayoun Zojaji, Hamid Mahboubi, Mahsa Molaei, Faramarz Derakhshan, Mohammadreza Zali. Quadruple versus common triple-treatment regimens for Helicobacter pylori eradication in the Iranian population: A randomised study. Arab Journal of Gastroenterology 2010; 11(4): 187 doi: 10.1016/j.ajg.2010.09.001
|
2 |
Seyedali Seyedmajidi, Dariush Mirsattari, Homayoun Zojaji, Elahe Zanganeh, Mohammadreza Seyyedmajidi, Shohreh Almasi, Mohammadreza Zali. Penbactam for Helicobacter pylori eradication: A randomised comparison of quadruple and triple treatment schedules in an Iranian population. Arab Journal of Gastroenterology 2013; 14(1): 1 doi: 10.1016/j.ajg.2012.12.004
|
3 |
Peter Malfertheiner, Steven F. Moss, Patrick Daniele, Corey Pelletier, Rinu Jacob, Gabriel Tremblay, Elizabeth Hubscher, Eckhard Leifke, William D. Chey. Potassium-Competitive Acid Blocker and Proton Pump Inhibitor–Based Regimens for First-Line Helicobacter pylori Eradication: A Network Meta-Analysis. Gastro Hep Advances 2022; 1(5): 824 doi: 10.1016/j.gastha.2022.06.009
|
4 |
Metin Küçükazman, Ayse Kefeli, Sebahat Basyigit, Abdullah Özgür Yeniova, Yasar Nazligül, Ibrahim Halil Akkus, Ayla Tezer, Servet Guresci. Efficacy of Bismuth-Containing Quadruple Therapy as
First-line Treatment for Helicobacter pylori Infection. Euroasian Journal of Hepato-Gastroenterology 2012; 2(2): 90 doi: 10.5005/jp-journals-10018-1041
|
5 |
Pinaki Ghosh, Amit D Kandhare, Divya Gauba, Kiran S Raygude, Subhash L Bodhankar. Determination of efficacy, adverse drug reactions and cost effectiveness of three triple drug regimens for the treatment of Helicobacter pylori infected acid peptic disease patients. Asian Pacific Journal of Tropical Disease 2012; 2: S783 doi: 10.1016/S2222-1808(12)60265-5
|
6 |
Yuan Wenzhen, Yang Kehu, Ma Bin, Li Yumin, Guan Quanlin, Wang Donghai, Yang Lijuan. Moxifloxacin-Based Triple Therapy Versus Clarithromycin-Based Triple Therapy for First-Line Treatment of Helicobacter pylori Infection: A Meta-Analysis of Randomized Controlled Trials. Internal Medicine 2009; 48(24): 2069 doi: 10.2169/internalmedicine.48.2344
|
7 |
AS Wong, SS Ching, AS Long. The use of a second biopsy from the gastric body for the detection of Helicobacter pylori using rapid urease test. Singapore Medical Journal 2014; 55(12): 644 doi: 10.11622/smedj.2014178
|
8 |
Ming-Cheh Chen, Wei-Yi Lei, Jen-Shung Lin, Chih-Hsun Yi, Deng-Chyang Wu, Chi-Tan Hu. Levofloxacin-Amoxicillin/Clavulanate-Rabeprazole versus a Standard Seven-Day Triple Therapy for Eradication ofHelicobacter pyloriInfection. BioMed Research International 2014; 2014: 1 doi: 10.1155/2014/158520
|
9 |
Jay Luther, Peter D R Higgins, Phillip S Schoenfeld, Paul Moayyedi, Nimish Vakil, William D Chey. Empiric Quadruple vs. Triple Therapy for Primary Treatment of Helicobacter pylori Infection: Systematic Review and Meta-Analysis of Efficacy and Tolerability. American Journal of Gastroenterology 2010; 105(1): 65 doi: 10.1038/ajg.2009.508
|
10 |
F. Sierra, J.D. Forero, M. Rey. Tratamiento ideal del Helicobacter pylori: una revisión sistemática. Revista de Gastroenterología de México 2014; 79(1): 28 doi: 10.1016/j.rgmx.2013.03.003
|
11 |
Manas Kumar Panigrahi, Mohd Imran Chouhan, Vinay Kumar Hallur, Madhav Sameer Makashir, Chandan Kumar, Shivam Sethi, Hemanta Kumar Nayak, Biswa Mohan Padhy, Subash Chandra Samal. Comparison of the efficacies of triple, quadruple and sequential antibiotic therapy in eradicating Helicobacter pylori infection: A randomized controlled trial. Indian Journal of Gastroenterology 2023; 42(4): 517 doi: 10.1007/s12664-022-01322-8
|
12 |
Başak Çakır Güney, Tolga Düzenli, Yeşim Önal, Mustafa Kaplan, Alpaslan Tanoğlu. Favorable effects of close telephone follow-up on Helicobacter pylori eradication success. Anatolian Current Medical Journal 2021; 3(1): 10 doi: 10.38053/acmj.865053
|
13 |
Steven F. Moss, William D. Chey, Patrick Daniele, Corey Pelletier, Rinu Jacob, Gabriel Tremblay, Elizabeth Hubscher, Eckhard Leifke, Peter Malfertheiner. Brief communication: global temporal trends in the efficacy of clarithromycin-based regimens for the treatment of Helicobacter pylori infection. Therapeutic Advances in Gastroenterology 2023; 16 doi: 10.1177/17562848231167284
|
14 |
F. Sierra, J.D. Forero, M. Rey. Ideal treatment for Helicobacter pylori: A systematic review. Revista de Gastroenterología de México (English Edition) 2014; 79(1): 28 doi: 10.1016/j.rgmxen.2014.05.001
|
15 |
|